Table 5.
Pharmacologic recommendations for management of hypertension by the eighth joint national committee panel36
| Hypertensive population | Initial pharmacologic agents | Level of evidence |
|---|---|---|
| Non-African Americans (including those with diabetes) |
|
Grade B: Moderate recommendation |
| African Americans (including those with diabetes) | Grade B: Moderate recommendation for African Americans with diabetes, Grade C: Weak recommendation |